Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in Central Centrifugal Cicatricial Alopecia (CCCA)
NCT07843732Phase 2Completed
- Sponsor
- Raven Clinical Research
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in central centrifugal cicatricial alopecia (CCCA), sponsored by Raven Clinical Research. Started Oct 2024; status: completed.
02
Drugs
baricitinib
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT07843732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843732.